% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I4210093322&access=free
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{wischik2015-25550228,
  author  = {Wischik, C. M. and Staff, R. T. and Wischik, D. J. and Bentham, P. and Murray, A. D. and Storey, J. M. and Kook, K. A. and Harrington, C. R.},
  title   = {{Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-142874},
  pmid    = {25550228},
  url     = {https://doi.org/10.3233/jad-142874}
}

@article{hanlon2020-32152019,
  author  = {Hanlon, P. and Quinn, T. J. and Gallacher, K. I. and Myint, P. K. and Jani, B. D. and Nicholl, B. I. and Lowrie, R. and Soiza, R. L. and others},
  title   = {{Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties}},
  journal = {Annals of family medicine},
  year    = {2020},
  doi     = {10.1370/afm.2501},
  pmid    = {32152019},
  url     = {https://doi.org/10.1370/afm.2501}
}

@article{wischik2026-41570392,
  author  = {Wischik, C. M. and Stefanacci, R. and Bentham, P. and Gauthier, S. and Zetterberg, H. and Wilcock, G. K. and Froelich, L. and Burns, A. and MacSweeney, E. and Ballard, C. and others},
  title   = {{Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer's Disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2026.100480},
  pmid    = {41570392},
  url     = {https://doi.org/10.1016/j.tjpad.2026.100480}
}